Related Experiment Video
Updated: Jan 30, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Advanced stage melanoma therapies: Detailing the present and exploring the future
Chelsea Luther1, Umang Swami2, Jun Zhang2
1Department of Dermatology, Henry Ford Hospital, Detroit, MI, United States.
Abstract:
Metastatic melanoma therapies have proliferated over the last ten years. Prior to this, decades passed with only very few drugs available to offer our patients, and even then, those few drugs had minimal survival benefits. Many treatment options emerged over the last ten years with diverse mechanisms of action. Further, combination regimens have demonstrated superiority over monotherapy, especially for targeted agents. Each therapeutic combination possesses different advantages and side effect profiles. In this review, we outline the United States Food and Drug Administration-approved melanoma treatment agents and therapies currently in clinical development, focusing on combination approaches.
Insights
Recent advances offer numerous metastatic melanoma treatments, with combination therapies outperforming single drugs. This review details FDA-approved agents and emerging combination approaches for melanoma.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Metastatic melanoma treatment options were limited for decades, offering minimal survival benefits.
- Significant advancements in melanoma therapies have occurred in the last ten years.
- Diverse mechanisms of action characterize newly available treatment options.
Purpose of the Study:
- To review United States Food and Drug Administration-approved melanoma treatment agents.
- To outline therapies currently in clinical development for metastatic melanoma.
- To focus on the efficacy and application of combination treatment approaches.
Main Methods:
- Literature review of FDA-approved melanoma therapies.
- Analysis of clinical trial data for emerging treatments.
- Synthesis of information on combination regimens versus monotherapy.
Main Results:
- Combination regimens have shown superiority over monotherapy, particularly with targeted agents.
- Each therapeutic combination presents distinct advantages and side effect profiles.
- A wide array of treatment options with varied mechanisms of action are now available.
Conclusions:
- The landscape of metastatic melanoma treatment has dramatically evolved.
- Combination therapies represent a superior strategy for managing metastatic melanoma.
- Ongoing clinical development promises further advancements in melanoma treatment.
Related Concept Videos
Detailed Structure and Function of Lymph Nodes
From a histological perspective, lymph nodes can be split into two main areas: the superficial cortex and the deep medulla. The outer cortex is populated by dendritic cells, macrophages, and B lymphocytes, which are densely packed into follicles. When these B-lymphocytes are presented...
Gene Therapy
Stages of Infection
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Stages of General Anesthesia

